Picture of Sinopharm logo

1099 — Sinopharm News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

Merck to take legal action against unauthorized distributors of its COVID treatment in China

SHANGHAI, Jan 11 (Reuters) - Merck & Co  MRK.N  said on
Wednesday it would take legal action against some pharmaceutical
companies after noticing that some manufacturers were supplying
COVID-19 drugs to some provinces and cities saying the medicines
were authorized by Merck.
    It did not name the companies. 
    China's Sinopharm  1099.HK  is the only legally authorized
distributor of Merck's COVID-19 antiviral molnupiravir in China,
it said in a post on its official WeChat account in China.  
    It added it had started talks with Sinopharm on the drug's
production technology licence so that Sinopharm can produce and
supply the drug in China. 
 (Reporting by Brenda Goh
Editing by Mark Potter)
 ((brenda.goh@thomsonreuters.com; +86 (0) 21 2083 0088; Reuters
Messaging: brenda.goh.thomsonreuters.com@reuters.net))

Recent news on Sinopharm

See all news